FDA Inspection 1245603 — Janssen Research & Development
The FDA completed an inspection of Janssen Research & Development on Jun 14, 2024 in Spring House, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 14, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Spring House, PA (United States)
Additional Details
Bioanalytical BA/BE